Overview
- 12 inspections across 12 sites are on record.
- 27 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-12-17.
At a glance
Inspections
12
Sites
12
Observations
27
Career since
Apr 2024
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Norwich Pharmaceuticals, Inc. | 17 Dec 2025 | Human Drugs | |
| F. M. Howell & Company | 10 Oct 2025 | Human Drugs | On file |
| F. M. Howell & Company | 9 Oct 2025 | Human Drugs | |
| Ruspak Packaging Corporation | 7 Aug 2025 | Human Drugs | On file |
| US Salt, LLC | 26 Jun 2025 | Human Drugs |
Sites inspected
Norwich Pharmaceuticals, Inc.Norwich, United States1 insp.
F. M. Howell & CompanyElmira, United States1 insp.
F. M. Howell & CompanyElmira, United States1 insp.
Ruspak Packaging CorporationLyons, United States1 insp.
US Salt, LLCWatkins Glen, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Ruben C Quintana3 shared
Evan Tong2 shared
Nelson N Ayangho2 shared
Karishma G Gopaul1 shared
Mindy M Chou1 shared
James M Mason1 shared
Divek R Jumani1 shared
Ifechimere I Okafor1 shared
Alisha B Patel1 shared
Johnny D Nwankwo1 shared
Full investigator report
Get the verbatim findings behind Elena N Thomas' 27 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site